Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Picard Medical, Inc. (PMI), Methode Electronics, Inc. (MEI), Inspire Medical Systems, Inc. (INSP), and GRAIL, Inc. (GRAL)

$GRALPress releaseOct 9, 2026, 11:55 AM ETRead the release

Johnson Fistel, PLLP announced it is investigating potential fiduciary-duty claims on behalf of long-term shareholders of four companies, including GRAIL, Inc. (NASDAQ: GRAL). The GRAIL allegations reference a previously filed securities class action claiming executives made misleading statements about the NHS-Galleri trial, which failed to achieve its primary endpoint of a statistically significant reduction in Stage III and IV cancer diagnoses, disclosed on February 19, 2026.

AI analysis

Red flags1 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    GRAL: Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Picard Medical, Inc. (PMI), Methode Electronics, Inc. (MEI), Inspire Medical Systems, Inc. (INSP), and GRAIL, Inc. (GRAL) — AI Analysis | Signal8